{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:33:06Z","timestamp":1790393586998,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,15]]},"DOI":"10.1086\/522540","type":"journal-article","created":{"date-parts":[[2008,1,4]],"date-time":"2008-01-04T13:44:10Z","timestamp":1199454250000},"page":"S206-S212","source":"Crossref","is-referenced-by-count":18,"title":["Pathogenesis of HIV Disease: Opportunities for New Prevention Interventions"],"prefix":"10.1093","volume":"45","author":[{"given":"Anthony S.","family":"Fauci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,12,15]]},"reference":[{"key":"key\n\t\t\t\t20171014000301_ref1","volume-title":"A glance at the HIV\/AIDS epidemic. Rev","author":"Centers for Disease Control and Prevention (CDC)","year":"2007"},{"key":"key\n\t\t\t\t20171014000301_ref2","volume-title":"AIDS epidemic update. December","author":"Joint United Nations Program on AIDS, World Health Organization","year":"2006"},{"issue":"Supplement_4","key":"key\n\t\t\t\t20171014000301_ref3","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1086\/522543","article-title":"Legal and ethical implications of opt-out HIV testing","volume":"45","author":"Hanssens","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014000301_ref4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nm0703-847","article-title":"Transmission, acute HIV-1 infection and the quest for strategies to prevent infection","volume":"9","author":"Pope","year":"2003","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20171014000301_ref5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nri1848","article-title":"Microbicides and other topical strategies to prevent vaginal transmission of HIV","volume":"6","author":"Lederman","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20171014000301_ref6","first-page":"1076","article-title":"Human immunodeficiency virus (HIV) disease: AIDS and related disorders","volume-title":"Harrison's principles of internal medicine","author":"Fauci","year":"2005","edition":"16th ed."},{"key":"key\n\t\t\t\t20171014000301_ref7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.7326\/0003-4819-124-7-199604010-00006","article-title":"Immunopathogenic mechanisms of HIV infection","volume":"124","author":"Fauci","year":"1996","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014000301_ref8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ni1316","article-title":"HIV disease: fallout from a mucosal catastrophe?","volume":"7","author":"Brenchley","year":"2006","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20171014000301_ref9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrmicro794","article-title":"The role of sexually transmitted diseases in HIV transmission","volume":"2","author":"Galvin","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171014000301_ref10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/sti.2005.015040","article-title":"High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India","volume":"82","author":"Reynolds","year":"2006","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t20171014000301_ref11","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1086\/368357","article-title":"Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India","volume":"187","author":"Reynolds","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014000301_ref12","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(06)69765-1","article-title":"Neglected tropical diseases and HIV\/AIDS","volume":"368","author":"Hotez","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014000301_ref13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1097\/00002030-200009290-00002","article-title":"Concurrent infections and HIV pathogenesis","volume":"14","author":"Bentwich","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014000301_ref14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-3024.2006.00918.x","article-title":"HIV and helminth co-infection: is deworming necessary?","volume":"28","author":"Borkow","year":"2006","journal-title":"Parasite Immunol"},{"key":"key\n\t\t\t\t20171014000301_ref15","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1086\/317623","article-title":"Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro","volume":"182","author":"Gopinath","year":"2000","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014000301_ref16","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1086\/444543","article-title":"Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults","volume":"192","author":"Modjarrad","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014000301_ref17","first-page":"165","article-title":"Impact of tuberculosis on HIV-1 replication, diversity, and disease progression","volume":"4","author":"Collins","year":"2002","journal-title":"AIDS Rev"},{"key":"key\n\t\t\t\t20171014000301_ref18","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.157.3.1271","article-title":"Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation","volume":"157","author":"Goletti","year":"1996","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20171014000301_ref19","first-page":"233","article-title":"Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study","volume":"365","author":"Kublin","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014000301_ref20","article-title":"An analytical overview of the microbicide preclinical and clinical pipeline [poster]","volume-title":"Program and abstracts of the XVI International AIDS Conference (Toronto, Canada)","author":"Finley","year":"2006"},{"key":"key\n\t\t\t\t20171014000301_ref21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJMcibr043727","article-title":"Topical microbicides become topical","volume":"352","author":"Moore","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014000301_ref22","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1097\/00002030-200010200-00018","article-title":"Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis","volume":"14","author":"Weiss","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014000301_ref23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":"Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014000301_ref24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":"Male circumcision for HIV prevention in men in Rakai, Uganda: a randomized trial","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014000301_ref25","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":"Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20171014000301_ref26","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1136\/bmj.320.7249.1592","article-title":"How does male circumcision protect against HIV infection?","volume":"320","author":"Szabo","year":"2000","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20171014000301_ref27","volume-title":"Male circumcision and risk for HIV transmission: implications for the United States","author":"Centers for Disease Control and Prevention (CDC)","year":"2007"},{"key":"key\n\t\t\t\t20171014000301_ref28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/00002030-200304110-00027","article-title":"Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?","volume":"17","author":"Youle","year":"2003","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20171014000301_ref29","volume-title":"CDC trials of pre-exposure prophylaxis for HIV prevention","author":"Centers for Disease Control and Prevention (CDC)","year":"2007"},{"key":"key\n\t\t\t\t20171014000301_ref30","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1086\/507314","article-title":"Chemoprophylaxis of HIV infection: moving forward with caution","volume":"194","author":"Grant","year":"2006","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014000301_ref31","volume-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 10 October","author":"US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2006"},{"issue":"RR-2","key":"key\n\t\t\t\t20171014000301_ref32","first-page":"1","article-title":"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the US Department of Health and Human Services. US Department of Health and Human Services","volume":"54","author":"Smith","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"RR-9","key":"key\n\t\t\t\t20171014000301_ref33","first-page":"1","article-title":"Updated US Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. US Public Health Service","volume":"54","author":"Panlilio","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20171014000301_ref34","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","article-title":"Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. Women and Infants' Transmission Study Group","volume":"29","author":"Cooper","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20171014000301_ref35","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Viral load heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group","volume":"342","author":"Quinn","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014000301_ref36","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(00)04331-2","article-title":"Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Rakai Project Team","volume":"357","author":"Gray","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014000301_ref37","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1086\/429411","article-title":"Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda","volume":"191","author":"Wawer","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014000301_ref38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.02.005","article-title":"The rational design of an AIDS vaccine","volume":"124","author":"Douek","year":"2006","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171014000301_ref39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nri1959","article-title":"Progress and obstacles in the development of an AIDS vaccine","volume":"6","author":"Letvin","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20171014000301_ref40","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1128\/JVI.00171-06","article-title":"Vaccine-induced cellular immune responses reduce plasma viral concentration after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239","volume":"80","author":"Wilson","year":"2006","journal-title":"J Virol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/45\/Supplement_4\/S206\/20907613\/45-Supplement_4-S206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T01:34:30Z","timestamp":1708479270000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/45\/Supplement_4\/S206\/454681\/Pathogenesis-of-HIV-Disease-Opportunities-for-New"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,15]]},"references-count":40,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2007,12,15]]},"published-print":{"date-parts":[[2007,12,15]]}},"URL":"https:\/\/doi.org\/10.1086\/522540","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,12,15]]},"published":{"date-parts":[[2007,12,15]]}}}